244 related articles for article (PubMed ID: 24521550)
21. Factors influencing the outcome of regenerative therapy in mandibular Class II furcations: Part I.
Bowers GM; Schallhorn RG; McClain PK; Morrison GM; Morgan R; Reynolds MA
J Periodontol; 2003 Sep; 74(9):1255-68. PubMed ID: 14584858
[TBL] [Abstract][Full Text] [Related]
22. Enamel matrix proteins in the regenerative therapy of deep intrabony defects.
Tonetti MS; Lang NP; Cortellini P; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Mayfield L; Rossi R; Silvestri M; Tiedemann C; Topoll H; Vangsted T; Wallkamm B
J Clin Periodontol; 2002 Apr; 29(4):317-25. PubMed ID: 11966929
[TBL] [Abstract][Full Text] [Related]
23. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects.
Gamal AY; Mailhot JM
J Int Acad Periodontol; 2008 Oct; 10(4):106-17. PubMed ID: 19055224
[TBL] [Abstract][Full Text] [Related]
24. Surgical Treatment of Furcation Involvement Associated with Recurrence of Aggressive Periodontitis: A Case Report.
Irokawa D; Bizenjima T; Imamura K; Inagaki S; Saito A; Tomita S
Bull Tokyo Dent Coll; 2020 Dec; 61(4):265-273. PubMed ID: 33177273
[TBL] [Abstract][Full Text] [Related]
25. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
[TBL] [Abstract][Full Text] [Related]
26. Progression of periodontitis in a sample of regular and irregular compliers under maintenance therapy: a 3-year follow-up study.
Oliveira Costa F; Miranda Cota LO; Pereira Lages EJ; Medeiros Lorentz TC; Soares Dutra Oliveira AM; Dutra Oliveira PA; Costa JE
J Periodontol; 2011 Sep; 82(9):1279-87. PubMed ID: 21342000
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
[TBL] [Abstract][Full Text] [Related]
28. Compliance and its role in successful treatment of an advanced periodontal case: review of the literature and a case report.
Soolari A
Quintessence Int; 2002 May; 33(5):389-96. PubMed ID: 12014170
[TBL] [Abstract][Full Text] [Related]
29. One-year effects of vitamin D and calcium supplementation on chronic periodontitis.
Garcia MN; Hildebolt CF; Miley DD; Dixon DA; Couture RA; Spearie CL; Langenwalter EM; Shannon WD; Deych E; Mueller C; Civitelli R
J Periodontol; 2011 Jan; 82(1):25-32. PubMed ID: 20809866
[TBL] [Abstract][Full Text] [Related]
30. Cross-sectional study of vitamin D and calcium supplementation effects on chronic periodontitis.
Miley DD; Garcia MN; Hildebolt CF; Shannon WD; Couture RA; Anderson Spearie CL; Dixon DA; Langenwalter EM; Mueller C; Civitelli R
J Periodontol; 2009 Sep; 80(9):1433-9. PubMed ID: 19722793
[TBL] [Abstract][Full Text] [Related]
31. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
[TBL] [Abstract][Full Text] [Related]
32. Prospective assessment of the use of enamel matrix proteins with minimally invasive surgery.
Harrel SK; Wilson TG; Nunn ME
J Periodontol; 2005 Mar; 76(3):380-4. PubMed ID: 15857071
[TBL] [Abstract][Full Text] [Related]
33. Surgical Periodontal Therapy with Recombinant Human Fibroblast Growth Factor-2 in Treatment of Chronic Periodontitis: A Case Report with 2-year Follow-up.
Matsugami D; Aoki H; Saito A
Bull Tokyo Dent Coll; 2021 Jun; 62(2):127-134. PubMed ID: 33994424
[TBL] [Abstract][Full Text] [Related]
34. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
Mengel R; Schreiber D; Flores-de-Jacoby L
J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Chronic Periodontitis with Smoking Cessation Care and Periodontal Surgery in an Elderly Patient: A Case Report Including a 4-year Follow-up.
Yamashita K; Seshima F; Kigure T; Tomita S; Saito A
Bull Tokyo Dent Coll; 2022 Mar; 63(1):31-40. PubMed ID: 35173085
[TBL] [Abstract][Full Text] [Related]
36. A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months.
Meyle J; Hoffmann T; Topoll H; Heinz B; Al-Machot E; Jervøe-Storm PM; Meiss C; Eickholz P; Jepsen S
J Clin Periodontol; 2011 Jul; 38(7):652-60. PubMed ID: 21564156
[TBL] [Abstract][Full Text] [Related]
37. Factors influencing treatment outcomes in mandibular Class II furcation defects.
Tsao YP; Neiva R; Al-Shammari K; Oh TJ; Wang HL
J Periodontol; 2006 Apr; 77(4):641-6. PubMed ID: 16584345
[TBL] [Abstract][Full Text] [Related]
38. Periodontal Regenerative Therapy with Recombinant Human Fibroblast Growth Factor-2 and Deproteinized Bovine Bone Mineral in Patient with Chronic Periodontitis: An 18-month Follow-up Report.
Bizenjima T; Irokawa D; Tanaka K; Saito A; Tomita S
Bull Tokyo Dent Coll; 2021 Jun; 62(2):107-117. PubMed ID: 33994421
[TBL] [Abstract][Full Text] [Related]
39. Deproteinized bovine bone in association with guided tissue regeneration or enamel matrix derivatives procedures in aggressive periodontitis patients: a 1-year retrospective study.
Artzi Z; Tal H; Platner O; Wasersprung N; Weinberg E; Slutzkey S; Gozali N; Carmeli G; Herzberg R; Kozlovsky A
J Clin Periodontol; 2015 Jun; 42(6):547-56. PubMed ID: 25950086
[TBL] [Abstract][Full Text] [Related]
40. Surgical Periodontal Therapy Using Recombinant Human Fibroblast Growth Factor-2 in Combination with Carbonate Apatite Granules for Stage III Grade B Periodontitis: A Case Report with 1-year Follow-up.
Murakami T; Imamura K; Watanabe-Egawa N; Tomita S; Saito A
Bull Tokyo Dent Coll; 2022 Sep; 63(3):145-153. PubMed ID: 35965084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
